Ingo Kausch

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

Merle Hanke, Kai P. Hoefig, Hartmut Merz et al. · Urologic Oncology Seminars and Original Investigations · 2009 · 636 citations

Tumor Biology, Urinary Bladder Cancer, Urology +14

Antisense treatment against Ki‐67 mRNA inhibits proliferation and tumor growth <i>in vitro</i> and <i>in vivo</i>

Ingo Kausch, Anja Lingnau, Elmar Endl et al. · International Journal of Cancer · 2003 · 95 citations · Full text

The expression of Ki‐67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells

Elmar Endl, Ingo Kausch, Martina Baack et al. · The Journal of Pathology · 2001 · 82 citations

P16 Immunoreactivity Is an Independent Predictor of Tumor Progression in Minimally Invasive Urothelial Bladder Carcinoma

Stefan Krüger, Ingo Kausch, Alfred C. Feller · European Urology · 2005 · 80 citations

P16 Immunoreactivity, Urology, Perineural Invasion +7

Detailed Technical Analysis of Urine RNA-Based Tumor Diagnostics Reveals ETS2/Urokinase Plasminogen Activator to Be a Novel Marker for Bladder Cancer

Merle Hanke, Ingo Kausch, Gerlinde Dahmen et al. · Clinical Chemistry · 2007 · 45 citations · Full text